» Articles » PMID: 20353940

The Human Cdc34 Carboxyl Terminus Contains a Non-covalent Ubiquitin Binding Activity That Contributes to SCF-dependent Ubiquitination

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Apr 1
PMID 20353940
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cdc34 is an E2 ubiquitin-conjugating enzyme that functions in conjunction with SCF (Skp1.Cullin 1.F-box) E3 ubiquitin ligase to catalyze covalent attachment of polyubiquitin chains to a target protein. Here we identified direct interactions between the human Cdc34 C terminus and ubiquitin using NMR chemical shift perturbation assays. The ubiquitin binding activity was mapped to two separate Cdc34 C-terminal motifs (UBS1 and UBS2) that comprise residues 206-215 and 216-225, respectively. UBS1 and UBS2 bind to ubiquitin in the proximity of ubiquitin Lys(48) and C-terminal tail, both of which are key sites for conjugation. When bound to ubiquitin in one orientation, the Cdc34 UBS1 aromatic residues (Phe(206), Tyr(207), Tyr(210), and Tyr(211)) are probably positioned in the vicinity of ubiquitin C-terminal residue Val(70). Replacement of UBS1 aromatic residues by glycine or of ubiquitin Val(70) by alanine decreased UBS1-ubiquitin affinity interactions. UBS1 appeared to support the function of Cdc34 in vivo because human Cdc34(1-215) but not Cdc34(1-200) was able to complement the growth defect by yeast Cdc34 mutant strain. Finally, reconstituted IkappaBalpha ubiquitination analysis revealed a role for each adjacent pair of UBS1 aromatic residues (Phe(206)/Tyr(207), Tyr(210)/Tyr(211)) in conjugation, with Tyr(210) exhibiting the most pronounced catalytic function. Intriguingly, Cdc34 Tyr(210) was required for the transfer of the donor ubiquitin to a receptor lysine on either IkappaBalpha or a ubiquitin in a manner that depended on the neddylated RING sub-complex of the SCF. Taken together, our results identified a new ubiquitin binding activity within the human Cdc34 C terminus that contributes to SCF-dependent ubiquitination.

Citing Articles

Cullin-RING ligases employ geometrically optimized catalytic partners for substrate targeting.

Li J, Purser N, Liwocha J, Scott D, Byers H, Steigenberger B Mol Cell. 2024; 84(7):1304-1320.e16.

PMID: 38382526 PMC: 10997478. DOI: 10.1016/j.molcel.2024.01.022.


Mechanism of millisecond Lys48-linked poly-ubiquitin chain formation by cullin-RING ligases.

Liwocha J, Li J, Purser N, Rattanasopa C, Maiwald S, Krist D Nat Struct Mol Biol. 2024; 31(2):378-389.

PMID: 38326650 PMC: 10873206. DOI: 10.1038/s41594-023-01206-1.


A context-dependent and disordered ubiquitin-binding motif.

Dreier J, Prestel A, Martins J, Brondum S, Nielsen O, Garbers A Cell Mol Life Sci. 2022; 79(9):484.

PMID: 35974206 PMC: 9381478. DOI: 10.1007/s00018-022-04486-w.


Branched ubiquitin chain binding and deubiquitination by UCH37 facilitate proteasome clearance of stress-induced inclusions.

Song A, Hazlett Z, Abeykoon D, Dortch J, Dillon A, Curtiss J Elife. 2021; 10.

PMID: 34761751 PMC: 8635973. DOI: 10.7554/eLife.72798.


The disordered PCI-binding human proteins CSNAP and DSS1 have diverged in structure and function.

Ruidiaz S, Dreier J, Hartmann-Petersen R, Kragelund B Protein Sci. 2021; 30(10):2069-2082.

PMID: 34272906 PMC: 8442969. DOI: 10.1002/pro.4159.


References
1.
Mach H, Middaugh C, Lewis R . Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal Biochem. 1992; 200(1):74-80. DOI: 10.1016/0003-2697(92)90279-g. View

2.
Choi Y, Jeon Y, Ryu K, Cheong C . 60th residues of ubiquitin and Nedd8 are located out of E2-binding surfaces, but are important for K48 ubiquitin-linkage. FEBS Lett. 2009; 583(20):3323-8. DOI: 10.1016/j.febslet.2009.09.034. View

3.
Prendergast J, Ptak C, Arnason T, Ellison M . Increased ubiquitin expression suppresses the cell cycle defect associated with the yeast ubiquitin conjugating enzyme, CDC34 (UBC3). Evidence for a noncovalent interaction between CDC34 and ubiquitin. J Biol Chem. 1995; 270(16):9347-52. DOI: 10.1074/jbc.270.16.9347. View

4.
Pickart C . Back to the future with ubiquitin. Cell. 2004; 116(2):181-90. DOI: 10.1016/s0092-8674(03)01074-2. View

5.
Kamura T, Koepp D, Conrad M, Skowyra D, Moreland R, Iliopoulos O . Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science. 1999; 284(5414):657-61. DOI: 10.1126/science.284.5414.657. View